Skip to main content
Daniel Clayburgh, MD, Otolaryngology (ENT), Portland, OR, OHSU Hospital

DanielRobertClayburghMD

Otolaryngology (ENT) Portland, OR

Physician

Dr. Clayburgh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Clayburgh's full profile

Already have an account?

Education & Training

  • Oregon Health & Science University
    Oregon Health & Science UniversityResidency, Otolaryngology - Head and Neck Surgery, 2008 - 2013
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2008

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 2014 - 2025
  • PA State Medical License
    PA State Medical License 2013 - 2014
  • American Board of Otolaryngology - Head and Neck Surgery Otolaryngology

Awards, Honors, & Recognition

  • Fellow (FAAO-HNS) American Academy of Otolaryngology - Head and Neck Surgery

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Association of Sarcopenia with Oncologic Outcomes of Primary Surgery or Definitive Radiotherapy Among Patients with Localized Oropharyngeal Squamous Cell Carcinoma  
    Daniel Clayburgh, MD, JAMA Otolaryngology–Head & Neck Surgery
  • Comparison of Opioid Utilization Patterns After Major Head and Neck Procedures Between Hong Kong and the United States  
    Maisie Shindo, Peter Andersen, Mark Wax, Daniel Clayburgh, JAMA

Press Mentions

  • Analysis Suggests an ‘Urgent Need’ for Personalized Head and Neck Cancer Follow-Up
    Analysis Suggests an ‘Urgent Need’ for Personalized Head and Neck Cancer Follow-UpOctober 21st, 2022
  • Risk of Head and Neck Cancer in Patients with Prior Hematologic Malignant Tumors
    Risk of Head and Neck Cancer in Patients with Prior Hematologic Malignant TumorsMay 2nd, 2020

Professional Memberships

Hospital Affiliations